OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation
Shangxin Yang, Ashrit Multani, Jacob M. Garrigues, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2096-2096
Open Access | Times Cited: 8
Shangxin Yang, Ashrit Multani, Jacob M. Garrigues, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 2096-2096
Open Access | Times Cited: 8
Showing 8 citing articles:
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
The impact of remdesivir on SARS-CoV-2 evolution in vivo
Ted Ling-Hu, Lacy M. Simons, Estefany Rios-Guzman, et al.
JCI Insight (2025)
Open Access
Ted Ling-Hu, Lacy M. Simons, Estefany Rios-Guzman, et al.
JCI Insight (2025)
Open Access
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 2
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
(2024)
Open Access | Times Cited: 2
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 7
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 7
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access | Times Cited: 1
Lia Fiaschi, Camilla Biba, Ilenia Varasi, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 168-168
Open Access | Times Cited: 1
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments
Vladimir Novitsky, Curt G. Beckwith, Kristin Carpenter‐Azevedo, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1511-1511
Open Access
Vladimir Novitsky, Curt G. Beckwith, Kristin Carpenter‐Azevedo, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1511-1511
Open Access
A Day in the Life of a Medical Microbiology Director: Navigating the Diverse Duties as a Clinical Conductor
Karissa Culbreath, Peera Hemarajata, Richard B. Thomson, et al.
Clinical Microbiology Newsletter (2024) Vol. 47, pp. 14-20
Closed Access
Karissa Culbreath, Peera Hemarajata, Richard B. Thomson, et al.
Clinical Microbiology Newsletter (2024) Vol. 47, pp. 14-20
Closed Access
